3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Phase 3
1
Phase 1
1
Status
Not yet recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Lymphoma, Non-Hodgkin
1
Interventions
Methotrexate
48
Cyclophosphamide
47
Vincristine
39
Cytarabine
36
Dexamethasone
33
Mercaptopurine
32
pegaspargase
30
Doxorubicin
29
Daunorubicin
26
Etoposide
24
Asparaginase
23
Prednisone
22
Radiotherapy
18
Thioguanine
15
Leucovorin
14
Calcium Dobesilate
14
merphos
12
Prednisolone
12
blinatumomab
11
Hydrocortisone
10
Whole-Body Irradiation
9
dexamethasone acetate
8
azathiopurine
8
Methylprednisolone
8
Ifosfamide
8
Filgrastim
8
Cyclosporine
8
fludarabine
7
dexamethasone 21-phosphate
7
auricularum
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
CVAD protocol
×
Clear all
NCT07223190
2026-03-04
AUDAX
Amgen
Phase 3
Not yet recruiting
560 enrolled